OIG Approves Cash Equivalents Paid To Patients Participating In Contingency Management Program Offered Through Digital Health Technology - Food, Drugs, Healthcare, Life Sciences

While many contend that CM is an effective, evidence-based treatment, certain legal barriers limit, and often prevent, its widespread adoption and use.

Related Keywords

United States , ,United States Department Of Health ,Institutes Of Health ,Human Services ,Office Of Inspector ,Beneficiary Inducements ,United States Department ,Inspector General ,Advisory Opinion ,Regulatory Sprint ,Mondaq ,Oig Approves Cash Equivalents Paid To Patients Participating In Contingency Management Program Offered Through Digital Health Technology ,Food ,Drugs ,Healthcare ,Life Sciences ,Food And Drugs Law ,